Charles River at hold by Jefferies

Charles River Laboratories International was maintained at a hold rating and $47.50 price target by Jefferies & Co., Inc. analyst David Windley. The company's fourth-quarter results beat Jefferies' and consensus estimates, while management reaffirmed 2006 guidance set in December. Charles River reported non-GAAP earnings per share $0.59, compared with Jefferies' estimate of $0.56 and consensus estimate of $0.57. Sales for the fourth quarter came in at $291.2 million, compared with Jefferies' estimate of $283 million and consensus of $282.8 million. Shares of the Wilmington, Mass., pharmaceutical company were up $3.51, or 7.83%, at $48.36 on volume of 1,325,200 shares versus the three-month running average of 528,829 shares. (NYSE: CRL)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.